Soosten, L. v. (2025). Establishing experimental therapeutic modalities and CRISPR/Cas9 screening platforms to interrogate vulnerabilities in pediatric high-grade glioma.
Chicago-Zitierstil (17. Ausg.)Soosten, Laura von. Establishing Experimental Therapeutic Modalities and CRISPR/Cas9 Screening Platforms to Interrogate Vulnerabilities in Pediatric High-grade Glioma. Heidelberg, 2025.
MLA-Zitierstil (9. Ausg.)Soosten, Laura von. Establishing Experimental Therapeutic Modalities and CRISPR/Cas9 Screening Platforms to Interrogate Vulnerabilities in Pediatric High-grade Glioma. 2025.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.